Journals Journal of Pediatric Hematolog...

Journal of Pediatric Hematology/oncology
Emine Caliskan, Naz Paytoncu, Hanife G Düzkalır, Meral Arifoglu, Neriman Fistikcioglu, Hediye P Gunbey
BACKGROUND/AIM: To present MRI features of neck lymph nodes in benign and malignant conditions in the pediatric population. MATERIALS AND METHODS: MRIs of the neck of 51 patients aged 1 to 18 years (40 boys, 11 girls [10.08±4.73]) with lymph node biopsy were retrospectively analyzed. Those were grouped as benign including reactive (27 [52.9%]) and lymphadenitis (11 [21.6%]), and malignant (13 [25.5%]). The groups were evaluated multiparametrically in terms of quantitative and qualitative variables...
April 4, 2024: Journal of Pediatric Hematology/oncology
Evan Dimentberg, Marie-Pier Marceau, Alexandre Lachance, Samuel Bergeron-Gravel, Stephan Saikali, Louis Crevier, Catherine Bourget, Cynthia Hawkins, Nada Jabado, Panagiota Giannakouros, Samuele Renzi, Valérie Larouche
Diffuse intrinsic pontine gliomas are lethal tumors with a prognosis generally less than 1 year. Few cases of survivors of 5 years or more have been reported. This case report highlights the journey of a 9.5-year survivor who underwent 3 rounds of focal radiotherapy; she experienced 6 years of progression-free survival following the first round but ultimately succumbed to her disease. An autopsy revealed a favorable IDH1 mutation and the absence of H3K27M. This case reiterates the importance of extensive molecular analyses in diffuse intrinsic pontine gliomas and explores the potential benefit of re-irradiation in patients with positive responses and long periods of remission...
April 4, 2024: Journal of Pediatric Hematology/oncology
Ecem Yigit, Melis Gultekin, Burca Aydin, Tezer Kutluk, Sezin Yuce Sari, Saniye Ekinci, Diclehan Orhan, Ferah Yildiz
AIM: To evaluate the treatment results, prognostic parameters, and treatment-related toxicity in patients with Ewing sarcoma (ES)/primitive neuroectodermal tumor (PNET) of the chest wall who underwent surgery, chemotherapy, and radiotherapy (RT) in a tertiary referral center. METHODS: The data of 24 patients under 18 years of age with a histologic diagnosis of ES/PNET in the chest wall that received RT in our department between February 2003 and July 2020 were retrospectively evaluated...
April 3, 2024: Journal of Pediatric Hematology/oncology
Nancy Crego, Christian Douglas, Emily Bonnabeau, Kern Eason, Marian Earls, Paula Tanabe, Nirmish Shah
Adults and children with sickle cell disease (SCD) are predominantly African American, with pain-related health disparities. We examined opioid prescription fill patterns in adults and children with SCD and compared factors associated with fills in North Carolina Medicaid enrollees. Our retrospective cohort study included 955 enrollees diagnosed with SCD having at least one opioid fill. Associations were measured between two cohorts (12 and 24 mo of continuous enrollment) for the following characteristics: sex, age, enrollee residence, hydroxyurea adherence, comanagement, enrollment in Community Care North Carolina, prescription for short versus short and long-acting opioids, and emergency department reliance...
March 28, 2024: Journal of Pediatric Hematology/oncology
Monica Davini, Caroline Hastings, James Feusner
Hepatoblastoma is the most common liver malignancy in children. Treatment typically involves surgery and cisplatin-based chemotherapy. After therapy completion, children undergo repetitive surveillance imaging to screen for relapse, which occurs in <12% of cases. Monitoring for relapse has gradually shifted to serial determination of serum alpha-fetoprotein (AFP) alone as most cases have AFP elevation at the time of relapse. Little primary data supports, such a practice, however, and herein we present both our institutional experience with relapsed hepatoblastoma and a careful review of published literature on this topic...
March 27, 2024: Journal of Pediatric Hematology/oncology
Renato Gualtieri, Fanette Bernard, Klara Posfay-Barbe, Geraldine Blanchard-Rohner
No abstract text is available yet for this article.
March 13, 2024: Journal of Pediatric Hematology/oncology
Jagdish Prasad Meena, Aditya Kumar Gupta, Kana Ram Jat
No abstract text is available yet for this article.
March 11, 2024: Journal of Pediatric Hematology/oncology
Ian J Cohen
The lack of a consensus of accepted prognostic factors in hypothermia suggests an additional factor has been overlooked. Delayed rewarming thrombocytopenia (DRT) is a novel candidate for such a role. At body temperature, platelets undergoing a first stage of aggregation are capable of progression to a second irreversible stage of aggregation. However, we have shown that the second stage of aggregation does not occur below 32°C and that this causes the first stage to become augmented (first-stage platelet hyperaggregation)...
March 7, 2024: Journal of Pediatric Hematology/oncology
Francesca Stefanachi, Maria Carmen Affinita, Giulia Fichera, Arianna Tagarelli, Federica De Corti, Federico Rea, Gianni Bisogno
Germ cell tumors (GCTs) are a heterogeneous group of pediatric cancers. In up to one-third of male patients, a primary mediastinal location is associated with the presence of Klinefelter syndrome (KS). We describe a case of mediastinal GCT in a patient, with unacknowledged KS, that presented a relapse 7 years from diagnosis, that is, 2 years after the end of the follow-up program usually recommended for patients with GCT. There are no recommendations for screening for KS in patients with mediastinal GCT and there are no specific guidelines for surveillance of GCT in KS patients...
March 6, 2024: Journal of Pediatric Hematology/oncology
Tal Ben-Ami
Nasopharyngeal carcinoma (NPC) is a rare and locally aggressive form of childhood cancer. Treatment of pediatric NPC includes chemotherapy and radiotherapy. Most studies on the treatment of pediatric NPC are single-arm studies. With current treatment protocols survival rates for patients with nonmetastatic disease exceed 80%, although most children will have long-term treatment-related late effects. Efforts to reduce early and late toxicities include reduced radiotherapy doses in children with good responses to induction chemotherapy...
March 5, 2024: Journal of Pediatric Hematology/oncology
Krystelle Dagher, Claudia Benvenuti, Kathy Virag, Walid Habre
OBJECTIVE OF THE STUDY: Bone marrow aspiration and lumbar puncture are procedures frequently performed in pediatric oncology. We aimed at assessing the incidence and risk factors of perioperative complications in children undergoing these procedures under sedation or general anesthesia. METHODS: Based on the APRICOT study, we performed a secondary analysis, including 893 children undergoing bone marrow aspiration and lumbar puncture. The primary outcome was the incidence of perioperative complications...
March 4, 2024: Journal of Pediatric Hematology/oncology
James E Fisher, Kevin Mulieri, Elizabeth Finch, Jessica E Ericson
Resistant and refractory cytomegalovirus (CMV) viremia can limit the provision of chemotherapy due to myelosuppression and end-organ dysfunction. Few therapies are available for children with clinically significant CMV viremia. We successfully used maribavir for a 4-year-old patient with lymphoma to complete his chemotherapy course. Resistance to maribavir did result after many months of therapy.
March 1, 2024: Journal of Pediatric Hematology/oncology
Arhanti Sadanand, Pratik Patel, Erica Riedesel, Frank Berkowitz, Frank G Keller
Patients undergoing therapy for T cell acute lymphoblastic leukemia are at risk of infections during their treatment course. Cat scratch disease caused by Bartonella hensalae can masquerade as leukemic relapse and cause systemic infection. Obtaining a thorough exposure history may aid clinicians in making the diagnosis.
February 29, 2024: Journal of Pediatric Hematology/oncology
Irina I Kalinina, Khristina S Antonova, Pavel V Avdonin, Elizaveta E Klebanova, Natalia N Kotskaya, Elena E Kurnikova, Alexandra D Shutova, Victor E Matveev, Alexey A Maschan
Acquired thrombotic thrombocytopenic (aTTP) purpura is a life-threatening condition that can lead to devastating thromboembolic events. Recently, caplacizumab has been shown to rapidly restore platelet numbers and reduce the risk of severe end-organ damage when added to plasma exchanges (PEXs) and immunosuppression (IST). Here, we report the outcomes in 3 children with aTTP who were treated with caplacizumab in combination with PEXs and IST. In all 3 patients, platelet count increased to >15,000/mm3 in 24 h and normalized on day 4, whereas normalization of ADAMTS13 activity >50% and elimination of the inhibitor was achieved after 18 to 89 days...
February 29, 2024: Journal of Pediatric Hematology/oncology
Alok Singh, Dhyuti Gupta
No abstract text is available yet for this article.
February 29, 2024: Journal of Pediatric Hematology/oncology
Durmus Durmaz, Ayca Dilruba Aslanger, Zehra Yavas Abali, Yasin Yilmaz, Volkan Karaman, Gozde Yesil Sayin, Guven Toksoy, Aysegul Unuvar, Zehra Oya Uyguner
BACKGROUND: Multisystemic findings of inherited bone marrow failure syndromes may cause difficulty in diagnosis. Exome sequencing (ES) helps to define the etiology of rare diseases and reanalysis offers a valuable new diagnostic approach. Herein, we present the clinical and molecular characteristics of a girl who was referred for cytopenia and frequent infections. CASE REPORT: A 5-year-old girl with cytopenia, dysmorphism, short stature, developmental delay, and myopia was referred for genetic counseling...
February 27, 2024: Journal of Pediatric Hematology/oncology
Patricia Bugeda Gómez, Adrià Costa-Roig, Carolina Montecino Romanini, Ignacio Miró Rubio, Santiago Guindos Rúa, Diana C Lara Cárdenas, Micaela Germani, María Roca Roca, Cleofe Romagosa Pérez Portabella, Marta Garrido Pontnou, Javier Hernández Losa, Luis F Sanchís Solera
The plexiform fibromyxoma is a rare mesenchymal tumor in adults that generally originates in the antrum of stomach, being its occurrence in pediatric patients exceptional. It was classified as a distinct entity by World Health Organization in 2010. No recurrences and metastases have been documented in many of the reported patients to date, being the surgical treatment curative. We report the case of a 3-month-old infant who presented to the emergency department with an episode of intestinal subocclusion requiring an emergent surgery...
February 26, 2024: Journal of Pediatric Hematology/oncology
Xiao-Yu Jing, Cheng-Qi Shen, Guo-Qian He, Rong-Rong Xu, Ju Gao, Xia Guo
INTRODUCTION: Desmoplastic small round cell tumor (DSRCT) is a highly aggressive primitive sarcoma with a 5-year survival rate estimated at only 15% to 30%. Although few curative treatment options exist, patients are most often treated with a combination of aggressive chemotherapy, radiation, and surgery. Targeted therapy inhibitors of platelet-derived growth factor A, insulin-like growth factor receptor 1, and vascular endothelial growth factor receptor-2, which are almost uniformly overexpressed in DSRCT, have largely failed in clinical trials...
February 22, 2024: Journal of Pediatric Hematology/oncology
Irtiza N Sheikh, Olayinka Okeleji, Rabya Afzal, Eliana Bonfante, Monica Kodakandla, Neethu M Menon
Spontaneous subgaleal hematoma in pediatric patients with sickle cell disease (SCD) is a rare occurrence that can present with symptoms mimicking ischemic stroke, a known complication of SCD. However, unlike ischemic stroke, subgaleal hematoma is nonlethal and can be managed conservatively without major sequelae. Here, we present the case of an adolescent with SCD who presented with 2 episodes of subgaleal and epidural hematomas, 2 years apart. The latter episode occurred while on crizanlizumab, an anti-P-selectin antibody, approved for use in SCD in 2019 to reduce the number of acute pain crises...
February 19, 2024: Journal of Pediatric Hematology/oncology
Sook Min Hwang, So-Young Yoo, Woo Kyoung Jeong, Min Woo Lee, Tae Yeon Jeon, Ji Hye Kim
OBJECTIVE: To investigate superb microvascular imaging (SMI), a novel Doppler ultrasound technique that can visualize low-velocity microvascular flow, for assessing pediatric focal nodular hyperplasia (FNH). PATIENTS AND METHODS: Nine FNH lesions in 6 patients were enrolled. On SMI and color Doppler imaging (CDI), intralesional vascularity was assessed visually and categorized as typical spoke-wheel pattern (central vessel radiating from the center to the periphery), multifocal spoke-wheel pattern, and nonspecific pattern...
February 19, 2024: Journal of Pediatric Hematology/oncology
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.